New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 26, 2014
07:26 EDTCRL, CVDCharles River Labs Covance outlooks have improved, says RW Baird
After attending the SOT conference, RW Baird believes that Charles River Labs (CRL) and Covance (CVD) are benefiting from multiple positive trends. The firm is increasingly comfortable with the 2014 guidance for Charles River and CVD Early Development, and thinks that current targets could prove conservative. It keeps Outperform ratings on both stocks.
News For CRL;CVD From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
July 30, 2015
16:16 EDTCRLCharles River files automatic mixed securities shelf
07:25 EDTCRLCharles River, AstraZeneca renew strategic partnership agreement
Charles River Laboratories International (CRL) announced that it has extended its initial three-year partnership with AstraZeneca (AZN) for an additional five-year period. Under the agreement, which extends into 2020, Charles River retains its position as AstraZeneca’s preferred strategic partner for outsourced regulated safety assessment and development DMPK.
07:24 EDTCRLCharles River raises FY15 adjusted EPS view to $3.60-$3.70 from $3.55-$3.65
Consensus is $3.64. Foreign currency translation is now expected to reduce earnings per share by approximately $0.10 in 2015, compared to the Company’s previous estimate of $0.17 per share. The improvement in foreign currency is being offset in part by lower expectations for Argenta and BioFocus. Primarily due to the acquisition of Celsis, revenue growth is now expected to be 8.0% to 9.5% on a constant-currency basis, compared to the prior range of 6.5% to 8.0%. Based on current rates, the Company expects foreign currency translation will reduce revenue growth by slightly more than 5.0%, which would result in reported revenue growth of 3.0% to 4.5%. The Company previously estimated a 5.5% impact from foreign currency translation and reported revenue growth of 1.0% to 2.5%.
07:23 EDTCRLCharles River to reopen facility in Shrewsbury, MA in early 2016
Subscribe for More Information
07:23 EDTCRLCharles River reports Q2 adjusted EPS 96c, consensus 97c
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use